The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians on the circulation of falsified chloroquine phosphate 250mg tablets.
In a statement, the Director-General of the agency, Prof Mojisola Adeyeye reportedly said that the NAFDAC was notified by the World Health Organisation (WHO) of the circulation of the tablets in Cameroon.
Adeyeye reportedly said that the falsified chloroquine phosphate 250mg tablets were manufactured by Jiangsu pharmaceutical Inc, Astral pharmaceutical New Bhupalpura, China. The tablets manufactured by these companies have no Active Pharmaceutical Ingredient (API) and are in packs of 1000 tablets.
Adeyeye warned that the use of the falsified chloroquine phosphate 250mg tablets may result in treatment failure and could even cause death.
Adeyeye reportedly said that the labelling information on the falsified chloroquine phosphate 250mg tablets manufactured by Jiangsu pharmaceutical Inc, China is labelled with fake NAFDAC No.: 028060. The Astral pharmaceuticals, New Bhupalpura, China is labelled with fake NAFDAC registration No. 0587612 and advised the general public to be aware of this drug.
NAFDAC caustioned all importers, wholesalers and retailers to desist from illegal importation, distribution and sale of falsified chloroquine phosphate 250mg tablets.
NAFDAC reportedly said that it has strengthened its surveillance in all ports of entry and has also heightened surveillance in the 36 states and the Federal Capital Territory (FCT) to prevent illegal importation and distribution of the falsified chloroquine phosphate 250mg tablets.
Healthcare providers and other members of the public are advised to be vigilant and contact the nearest NAFDAC office with any information on the falsified chloroquine and anybody in possession of the falsified chloroquine are to submit it to the nearest NAFDAC office.
Be the first to comment